EWTX   $31.88  -0.22% Market Open

Edgewise Therapeutics Inc
Total Cash 511.75M
totalCashPerShare 5.457
EBITDA -134.29M
Total Debt 4.99M
quickRatio 29.795
currentRatio 30.242
Total Revenue
debtToEquity 0.977
Revenue/Share
ROA -0.19740999
ROE -0.28197
grossProfits
freeCashflow -62.31M
operatingCashflow -103.58M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.93B
forwardPE -19.582888
floatShares 53.45M
sharesOutstanding 93.77M
sharesShort 8.49M
sharesShortPriorMonth 8.17M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.13%
Short Ratio help_outline 4.50%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 5.451
Price To Book help_outline 6.72
earningsQuarterlyGrowth
netIncomeToCommon -115.88M
trailingEps -1.56%
forwardEps -1.87%
enterpriseToEbitda -21.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 219
lastUpdated Nov. 7, 2024, 4:59 a.m.